BioWorld

May 7, 2003

View Archived Issues

Testing Primates' Visual Response Against Flagging GABA In Cerebral Cortex Reveals New Drug Resource

Read More

Neurogenetics Licenses Rights To Pain Compound From Lilly

Read More

Incyte Reports Falling Revenue; Splits Discovery, Information Units

Read More

Other News To Note

Read More

SARS: Revenue Generator Or Flash-In-The-Pan Illness?

Biotechnology oftentimes eases into the wake of U.S. - and global - burgeoning health risks. That wake occasionally allows companies to ride the waves of newfound investor interest. (BioWorld Today) Read More

European Sector Experiences Falloff In Revenues, Employees

Read More